Literature DB >> 6196400

Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.

J Holoshitz, A Frenkel, A Ben-Nun, I R Cohen.   

Abstract

Lines of T lymphocytes reactive against the basic protein of myelin (BP) were found in previous studies to mediate experimental autoimmune encephalomyelitis (EAE) in rats. Moreover, inoculation of rats with attenuated anti-BP line cells vaccinated them against subsequent attempts to induce active EAE by injection of BP in adjuvant. In the present study, we investigated the effects of T lymphocyte lines reactive to different antigenic determinants on the BP molecule, they are the major encephalitogenic peptide (EP) determinant present on guinea pig BP (G-BP), and minor, non-EP determinants present on bovine BP (B-BP). We found that both lines of T lymphocytes could mediate EAE. Resistance to active EAE acquired by spontaneous recovery from line mediated EAE or by vaccination with attenuated cells, however, was found to be specific for the particular BP determinant. Thus, EAE may be mediated by lines of T lymphocytes reactive to different determinants on the BP molecule, but the resistance to EAE acquired by exposure to line cells is determinant specific. This suggests that acquired resistance to EAE is directed by the receptor specificity of the autoimmune anti-BP T cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196400

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Post-infectious and post-vaccinal acute disseminated encephalomyelitis occurring in the same patients.

Authors:  Sabrina Ravaglia; Mauro Ceroni; Arrigo Moglia; Alessandra Todeschini; Enrico Marchioni
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes.

Authors:  Vily Panoutsakopoulou; Katharina M Huster; Nami McCarty; Evan Feinberg; Rijian Wang; Kai W Wucherpfennig; Harvey Cantor
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions.

Authors:  C P Broeren; M A Lucassen; M J van Stipdonk; R van der Zee; C J Boog; J G Kusters; W van Eden
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

4.  Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure.

Authors:  O Lider; N Karin; M Shinitzky; I R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

5.  Role of the thymus in induction and transfer of vaccination against adjuvant arthritis with a T lymphocyte line in rats.

Authors:  J Holoshitz; A Matitiau; I R Cohen
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).

Authors:  M I Perez; R L Edelson; L John; L Laroche; C L Berger
Journal:  Yale J Biol Med       Date:  1989 Nov-Dec

7.  Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone.

Authors:  M H Wauben; C J Boog; R van der Zee; I Joosten; A Schlief; W van Eden
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.